搜尋





搜尋





市場行情
/
股票
/
inbx
/

Inhibrx Biosciences Inc

INBX

添加自選

82.050USD

-2.680-3.16%

收盤 07-31 16:00（美東）報價延遲15分鐘

1.20B總市值

虧損本益比TTM

Inhibrx Biosciences Inc

82.050

-2.680-3.16%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

INBX 利潤表

您可以在這裡找到Inhibrx Biosciences Inc的年度或季度收入報告，以深入了解Inhibrx Biosciences Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

營業總收入

----

-100.00%0.00

--0.00

1200.00%1.30M

----

-93.88%100.00K

-100.00%0.00

233.33%100.00K

-100.00%0.00

496.35%1.63M

-57.19%119.00K

-95.78%30.00K

-98.17%17.00K

-90.41%274.00K

-89.02%278.00K

-25.47%711.00K

4.50%929.00K

2.88%2.86M

-57.09%2.53M

-71.43%954.00K

1.95%889.00K

--2.78M

--5.90M

4.05%3.34M

-89.77%872.00K

14.16%3.21M

205.05%8.52M

--2.27M

--722.00K

--2.81M

--2.79M

營業收入

----

-100.00%0.00

----

1200.00%1.30M

----

-93.88%100.00K

-100.00%0.00

233.33%100.00K

----

496.35%1.63M

-57.19%119.00K

-95.78%30.00K

-98.17%17.00K

-90.41%274.00K

-89.02%278.00K

-25.47%711.00K

4.50%929.00K

2.88%2.86M

-57.09%2.53M

-71.43%954.00K

1.95%889.00K

--2.78M

--5.90M

4.05%3.34M

-89.77%872.00K

14.16%3.21M

205.05%8.52M

--2.27M

--722.00K

--2.81M

--2.79M

營業費用

-27.91%30.93M

-38.19%30.92M

-27.75%33.81M

-82.18%28.69M

-41.89%42.90M

-44.37%50.03M

1.85%46.80M

289.18%161.00M

68.62%73.83M

151.36%89.92M

51.73%45.95M

17.17%41.37M

46.21%43.78M

60.71%35.77M

41.94%30.28M

70.12%35.31M

53.99%29.95M

11.95%22.26M

-0.59%21.33M

1.21%20.75M

5.22%19.45M

--19.88M

--21.46M

48.49%20.51M

52.35%18.48M

45.61%13.81M

3.78%12.13M

--6.35M

--10.58M

--9.48M

--11.69M

研發費用

-31.97%24.69M

-26.25%24.17M

-26.87%27.96M

-67.76%21.68M

-42.94%36.29M

-59.95%32.78M

1.16%38.23M

98.61%67.26M

71.19%63.59M

170.95%81.84M

53.13%37.80M

14.18%33.86M

50.79%37.15M

62.26%30.20M

33.53%24.68M

65.67%29.66M

49.88%24.64M

5.36%18.61M

-6.82%18.48M

-5.65%17.90M

-3.40%16.44M

--17.67M

--19.84M

55.86%18.97M

59.55%17.02M

43.31%12.17M

-1.06%10.66M

--4.68M

--9.50M

--8.49M

--10.78M

折舊攤銷及損耗

-20.44%537.00K

71.99%1.19M

-23.29%583.00K

39.08%662.00K

87.50%675.00K

131.21%689.00K

150.00%760.00K

61.36%476.00K

22.03%360.00K

-1.32%298.00K

-1.62%304.00K

-3.91%295.00K

-1.63%302.00K

3.34%309.00K

3.02%307.00K

5.50%307.00K

15.85%307.00K

20.08%299.00K

19.68%298.00K

13.67%291.00K

--265.00K

--249.00K

17.45%249.00K

33.33%256.00K

28.48%212.00K

27.15%192.00K

--199.00K

--161.00K

--165.00K

--151.00K

營業利潤

27.91%-30.93M

38.06%-30.92M

27.75%-33.81M

82.98%-27.39M

41.89%-42.90M

43.45%-49.93M

-2.12%-46.80M

-289.22%-160.90M

-68.68%-73.83M

-148.70%-88.29M

-52.74%-45.83M

-19.49%-41.34M

-50.83%-43.77M

-82.95%-35.50M

-59.58%-30.00M

-74.72%-34.60M

-56.36%-29.02M

-13.43%-19.40M

-20.84%-18.80M

-15.34%-19.80M

-5.38%-18.56M

---17.11M

---15.56M

-61.94%-17.17M

-387.57%-17.61M

-58.86%-10.60M

59.40%-3.61M

---4.08M

---9.86M

---6.67M

---8.90M

淨非營業利息收入（費用）

利息收入

-56.76%1.01M

-34.45%1.31M

-38.35%1.78M

-22.51%2.12M

-29.51%2.33M

-57.35%2.00M

24.44%2.89M

13.55%2.74M

--3.30M

--4.70M

--2.32M

--2.41M

----

利息費用

30.49%3.51M

--3.19M

--3.18M

-41.41%3.14M

-66.92%2.69M

-100.00%0.00

-32.18%5.36M

60.04%8.13M

53.84%8.22M

52.60%8.15M

151.11%7.91M

123.39%5.08M

200.45%5.34M

200.34%5.34M

244.42%3.15M

205.23%2.27M

234.40%1.78M

-59.85%1.78M

-73.16%914.00K

-69.60%745.00K

--532.00K

--4.43M

594.90%3.41M

892.31%2.45M

26.29%490.00K

-45.23%247.00K

--297.00K

--344.00K

--388.00K

--451.00K

特殊收入（費用）

----

--0.00

-100.00%0.00

----

--0.00

--2.02B

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---24.00K

--2.69M

---41.00K

----

--0.00

----

其他非經營性收入（費用）

76.00%-12.00K

-165.00%-39.00K

-212.20%-46.00K

-845.45%-246.00K

15.25%-50.00K

137.97%60.00K

130.37%41.00K

115.21%33.00K

15.71%-59.00K

-122.54%-158.00K

-850.00%-135.00K

-1376.47%-217.00K

-289.19%-70.00K

-1083.33%-71.00K

1900.00%18.00K

240.00%17.00K

131.25%37.00K

14.29%-6.00K

---1.00K

200.00%5.00K

60.00%16.00K

---7.00K

--0.00

-225.00%-5.00K

-16.67%10.00K

-66.67%4.00K

-57.14%12.00K

--14.00K

--12.00K

--28.00K

稅前利潤

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

47.96%-47.87M

15.30%-43.86M

4049.27%1.86B

-60.91%-78.71M

-124.79%-91.97M

-46.60%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.92M

-71.65%-35.33M

-82.17%-37.73M

-62.05%-31.25M

-20.08%-21.19M

-2.85%-20.58M

-15.80%-20.71M

4.01%-19.29M

---17.65M

---20.01M

-61.32%-17.89M

-422.30%-20.09M

-57.28%-11.09M

58.72%-3.85M

---4.37M

---10.19M

---7.05M

---9.32M

所得稅

--0.00

0.00%2.00K

--0.00

100.00%0.00

-100.00%0.00

-60.00%2.00K

----

-300.00%-4.00K

--2.00K

25.00%5.00K

--0.00

---1.00K

--0.00

--4.00K

-100.00%0.00

--0.00

--2.00K

--3.00K

--0.00

100.00%0.00

--0.00

---2.00K

--0.00

--46.00K

--50.00K

--0.00

除稅後的權益收益

----

---1.63M

----

--0.00

100.00%0.00

----

--0.00

---487.00K

----

除稅後利潤

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

47.96%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-124.78%-91.97M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-2.85%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.01M

-61.34%-17.89M

-422.30%-20.09M

-57.26%-11.09M

58.72%-3.85M

---4.41M

---10.24M

---7.05M

---9.32M

持續經營利潤

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.50M

-61.34%-17.89M

-422.30%-20.09M

-57.26%-11.09M

58.72%-3.85M

---4.41M

---10.24M

---7.05M

---9.32M

歸屬少數股東的淨利潤

----

--0.00

100.00%0.00

--0.00

---142.00K

---453.00K

歸属于母公司的淨利潤

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.50M

-61.34%-17.89M

-422.30%-20.09M

-54.90%-11.09M

58.88%-3.85M

---4.41M

---10.24M

---7.16M

---9.36M

歸屬普通股東的淨利潤

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.50M

-61.34%-17.89M

-422.30%-20.09M

-54.90%-11.09M

58.88%-3.85M

---4.41M

---10.24M

---7.16M

---9.36M

基本每股收益

23.37%-2.15

31.67%-2.11

19.68%-2.28

-101.46%-1.85

-94.07%-2.80

-78.82%-3.09

-158.18%-2.84

11888.42%127.10

-28.53%-1.44

-83.08%-1.73

-21.48%-1.10

-11.55%-1.08

-40.14%-1.12

-72.06%-0.94

-66.47%-0.90

-76.52%-0.97

-56.71%-0.80

-17.36%-0.55

0.08%-0.54

-12.23%-0.55

6.74%-0.51

---0.47

---0.54

-61.35%-0.49

-422.29%-0.55

-54.90%-0.30

58.88%-0.10

---0.12

---0.28

---0.20

---0.26

稀釋每股收益

23.37%-2.15

31.67%-2.11

19.68%-2.28

-101.48%-1.85

-94.07%-2.80

-78.82%-3.09

-158.18%-2.84

11738.74%125.48

-28.53%-1.44

-83.08%-1.73

-21.48%-1.10

-11.55%-1.08

-40.14%-1.12

-72.06%-0.94

-66.47%-0.90

-76.52%-0.97

-56.71%-0.80

-17.36%-0.55

0.08%-0.54

-12.23%-0.55

6.74%-0.51

---0.47

---0.54

-61.35%-0.49

-422.29%-0.55

-54.90%-0.30

58.88%-0.10

---0.12

---0.28

---0.20

---0.26

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Inhibrx Biosciences Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 INBX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Inhibrx Biosciences Inc 財年末的營收是多少？



Inhibrx Biosciences Inc 2025 財年營收為 1.30M，高於上一財年的 200.00K。

Inhibrx Biosciences Inc 全年的淨利潤是多少？



Inhibrx Biosciences Inc 2025 財年淨利潤為 -140.06M。

Inhibrx Biosciences Inc 上一季度的淨利潤是多少？



Inhibrx Biosciences Inc 最近一個季度的淨利潤為 -33.44M。

Inhibrx Biosciences Inc 年度營業利潤是多少？



Inhibrx Biosciences Inc 2025 財年的營業利潤為 -135.03M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。